5294 related articles for article (PubMed ID: 6091526)
1. Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.
Sezzi ML; Zupi G; De Luca G; Materazzi M; Bellelli L
Anticancer Res; 1984; 4(4-5):229-34. PubMed ID: 6091526
[TBL] [Abstract][Full Text] [Related]
2. Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis.
Sezzi ML; De Luca G; Materazzi M; Bellelli L
Anticancer Res; 1985; 5(3):265-71. PubMed ID: 4015040
[TBL] [Abstract][Full Text] [Related]
3. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
Kubo K; Matsuda Y; Kase H; Yamada K
Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
[TBL] [Abstract][Full Text] [Related]
5. Properties of acidic saccharides produced by B16 melanoma cells treated with 1-methyl-3-isobutylxanthine.
Banks J; Kreider JW; Sato C; Davidson EA
Cancer Res; 1975 Sep; 35(9):2383-9. PubMed ID: 167957
[TBL] [Abstract][Full Text] [Related]
6. Cardiac and haemodynamic effects of intravenous administrations of flunarizine in closed-chest anaesthetized mongrel dogs.
Kubo K; Van de Water A; Wouters L; Xhonneux R; Reneman RS
Arzneimittelforschung; 1984; 34(4):434-9. PubMed ID: 6430305
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of flunarizine on human lymphocytes.
Brohée D; Piro P; Kennes B; Nève P
Cytobios; 1986; 45(182-183):139-46. PubMed ID: 3731875
[TBL] [Abstract][Full Text] [Related]
8. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
Van Reempts J; Borgers M; Van Dael L; Van Eyndhoven J; Van De Ven M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
[TBL] [Abstract][Full Text] [Related]
9. Time course of the effect of flunarizine on rabbit isolated vascular muscle.
Wadsworth RM; Moss JP
Eur J Pharmacol; 1982 Nov; 85(2):207-9. PubMed ID: 7151868
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic studies with flunarizine, a calcium influx blocker.
Gulati N; Huggel H; Gulati OP
Arch Int Pharmacodyn Ther; 1983 May; 263(1):17-27. PubMed ID: 6615081
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.
Bellelli A; Camboni C; de Luca G; Materazzi M; Mattioni M; Sezzi ML; Bellelli L
Oncology; 1987; 44(1):17-23. PubMed ID: 3561923
[TBL] [Abstract][Full Text] [Related]
12. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
[TBL] [Abstract][Full Text] [Related]
13. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
14. Polymorphonuclear leukocyte as a model of Ca++ and Mg++-dependent cellular activation. Effect of flunarizine.
Di Perri T; Laghi Pasini F; Pasqui AL; Ceccatelli L; Capecchi PL; Orrico A
Microcirc Endothelium Lymphatics; 1984 Aug; 1(4):415-29. PubMed ID: 6100790
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines.
Nordenberg J; Perlmutter I; Lavie G; Beery E; Uziel O; Morgenstern C; Fenig E; Weizman A
Int J Oncol; 2005 Oct; 27(4):1097-103. PubMed ID: 16142328
[TBL] [Abstract][Full Text] [Related]
16. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
17. Brainstem auditory evoked potentials in migraine patients in basal conditions and after chronic flunarizine treatment.
Bussone G; Sinatra MG; Boiardi A; La Mantia L; Frediani F; Cocchini F
Cephalalgia; 1985 May; 5 Suppl 2():177-80. PubMed ID: 4016931
[TBL] [Abstract][Full Text] [Related]
18. Action of flunarizine and cinnarizine on calcium fluxes in synaptosomal preparations from rat cerebral cortex.
Wibo M; Delfosse I; Godfraind T
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):333-4. PubMed ID: 6882106
[No Abstract] [Full Text] [Related]
19. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of dipfluzine, flunarizine, and cinnarizine on 5-hydroxytryptamine-evoked contraction in pig basilar artery.
Zhu YH; Wang YL; Yang XP
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):321-3. PubMed ID: 9812713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
